Polymedco Cancer Diagnostic Products, LLC ("Polymedco CDP") is pleased to announce that a distribution agreement was signed with MedPrimex, LLC ("MedPrimex").
The agreement provides distribution rights, for the Mexican market, to MedPrimex for Polymedco CDP fecal immunochemical test (FIT) product line for screening for colorectal cancer (CRC). Colorectal cancer is among the leading causes of cancer death worldwide, but nearly half of people who die failed to get screened.
Early detection and treatment dramatically increase chances of survival. Screening is the most realistic approach to reducing new cases by finding non-cancerous colorectal polyps and removing them before they become cancerous.
The OC automated FIT and manual OC Light@ tests are quick and easy screening methods that measure human hemoglobin in the patient's stool. The tests can be performed at home with little disruption to the patient's daily routine - requiring only one sample collection and no changes to diet or medication. The higher specificity of FIT means that there are less false positive results.
"Our goal is to introduce the benefits of getting an annual screening using a fecal immunochemical test (FIT) to people of Mexico," said Drew Cervasio, President of Polymedco. "Innovations in screening have significantly improved the detection of breast, prostate and cervical cancers so it is time to pay attention to the advances that can drive more patients to find colorectal cancer earlier." "Through these screening tests, we are better able to accurately identify at-risk patients and send more of the right patients for further evaluation and colonoscopy," said Ana Maria Pedroza, CEO of MedPrimex. "We are proud to be a part of an effort that will ensure citizens of our country will have access to the best options for their healthcare needs." About Polymedco Cancer Diagnostic Products, LLC Polymedco Cancer Diagnostic Products, LLC is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace.
Polymedco supplies clinical diagnostic test kits and devices that are specialized in cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC -Auto@ product line. Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization.
Combined with an experienced team of field representatives and strong technical service personnel, Polymedco Cancer Diagnostic Products provides a high level of customer, technical and reimbursement support. To reach Polymedco Inc. via the worldwide web, log on to www.polymedco.com .
About MedPrimex, LLC MedPrimex is a trusted Mexican company specialized in providing medical equipment, early detection systems, and disease prevention to preserve the health of the Mexican population. MedPrimex has strong ties with lead companies to deliver innovative health system solutions and advance medical technology. MedPrimex goal is preserving the health and quality of life of people.
MedPrimex has unparalleled service, expertise, product, and service offerings - delivering solutions that are innovative and practical.
MedPrimex focuses on what matters most - improving people's lives.
MedPrimex strives to work for the success of their customers by providing exceptional value and superior service to best satisfy their needs.
To reach MedPrimex via the worldwide web, log on to www.medprimex.com.
SOURCE Polymedco Cancer Diagnostic Products, LLC -0- 08/30/2012 /CONTACT: Helen Landicho, Vice President of Regulatory Affairs, Polymedco Cancer Diagnostic Products, LLC, +1-206-402-6146, firstname.lastname@example.org or Roberto Pedroza, MedPrimex, LLC,+1-647-467-0085, email@example.com /Web Site: http://www.polymedco.com CO: Polymedco Cancer Diagnostic Products, LLC; MedPrimex, LLC ST: New York Mexico IN: BIO HEA MEQ SU: LIC PRN -- NY65700 -- 0000 08/30/2012 14:24:22 EDT http://www.prnewswire.c